Results 61 to 70 of about 1,436,927 (201)

Real‐World Effectiveness and Safety of Recombinant Human Follicle‐Stimulating Hormone (rhFSH) in Infertile Women undergoing Assisted Reproductive Technology (ART): A Korean Nationwide Cohort Study

Clinical Pharmacology &Therapeutics, Volume 119, Issue 2, Page 514-523, February 2026.
Despite widespread rhFSH use in infertile women undergoing ART, real‐world comparative data on its effectiveness and safety across different rhFSH types remain limited. Using the HIRA claims database, we included 10,684 women aged 20–39 with infertility (2016–2021) who used only rhFSH in their first in vitro fertilization–embryo transfer (IVF‐ET ...
Joong Yeup Lee, Eun‐Young Choi, Jung Ryeol Lee, Young Sik Choi, Ji Hyang Kim, Chang‐Woo Choo, Yunju Choe, Hee‐Jin Seo, Hyesung Lee, Yujeong Shin, Yejin Jeon, Ju‐Young Shin, Hoon Kim   +12 more
wiley   +1 more source

FSHR and LHR functional compensation reveals the mechanism and treatment of Ovarian Hyperstimulation Syndrome

Nature Communications
Gain-of-function mutations in the human follicle-stimulating hormone receptor (FSHR) cause spontaneous ovarian hyperstimulation syndrome (OHSS), a serious reproductive disorder.
Shanshan Lai, Yongjie Huang, Su Ma, Hongying Hao, Ao Dai, Xiaofei Yan, Jiabao Yang, Shuqian Wang, Qingqing Ren, Yan Zhang, Peng Hu, Jing Li, Xiaowei Zheng, Juergen Brosius, Cheng Deng   +14 more
doaj   +1 more source

The threshold of estradiol level for fresh embryo transfer differs between blastocyst and cleavage‐stage embryo

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 2, Page 257-267, February 2026.
Our results suggested that the difference in pregnancy outcomes between fresh and frozen embryo transfer is related to the peak estradiol level and embryo transfer stage. The cutoff values for peak estradiol level for performing freeze‐all strategy to improve pregnancy outcomes were different for cleavage‐stage and blastocyst‐stage embryo transfer ...
Dingying Zhao, Huiying Xiao, Gege Ouyang, Yuan Fang, Qiaoqiao Ding, Yue Niu, Jialin Zou, Yanran Liu, Xue Shang, Ze Wang, Zi‐Jiang Chen, Lianlian Liu, Daimin Wei   +12 more
wiley   +1 more source

Ovarian Hyperstimulation Syndrome as an Etiology of Obstructive Uropathy

Case Reports in Obstetrics and Gynecology, 2013
Ovarian hyperstimulation syndrome (OHSS) is an iatrogenic complication of controlled ovarian hyperstimulation (COH) protocols performed in women undergoing assisted reproductive technologies.
Creticus P. Marak, Amit Chopra, Narendrakumar Alappan, Ana M. Ponea, Achuta K. Guddati   +4 more
doaj   +1 more source

Undetectable Serum Levels of Anti-Müllerian Hormone in Women with Ovarian Hyperstimulation Syndrome during In Vitro Fertilization and Successful Pregnancy Outcome: Case Report

Acta Clinica Croatica, 2018
We report a unique case of undetectable serum levels of anti-müllerian hormone (AMH) in women with polycystic ovary syndrome (PCOS) who developed ovarian hyperstimulation syndrome (OHSS) during in vitro fertilization (IVF).
Ivan Grbavac, Ivana Zec, Dejan Ljiljak, Romina Rakoš Justament, Željka Bukovec Megla, Krunoslav Kuna   +5 more
doaj   +1 more source

Prognostic role of follicular fluid tumor necrosis factor alpha in the risk of early ovarian hyperstimulation syndrome

BMC Pregnancy and Childbirth, 2020
Background Ovarian hyperstimulation syndrome (OHSS) is an iatrogenic condition characterized by capillary hyperpermeability which can be predicted by preovulatory ovarian responses such as number of follicles.
Miaad Jabbar Alhilali, Abbas Parham, Armin Attaranzadeh, Malihe Amirian, Mohammad Azizzadeh   +4 more
doaj   +1 more source

Live Birth Following Dibutyryl‐cAMP‐Enhanced Biphasic in Vitro Maturation of Ovarian Tissue Oocytes From a Patient With Ovarian Fibromatosis: A First Report

Reproductive Medicine and Biology, Volume 25, Issue 1, January/December 2026.
ABSTRACT Case A 23‐year‐old nulligravida with bilateral ovarian fibromatosis, amenorrhea, and severe ovulatory dysfunction was diagnosed via laparoscopic biopsy. As pregnancy was desired but transvaginal oocyte retrieval was not feasible due to dense fibrosis, partial ovarian resection was performed, and oocytes were obtained using ovarian tissue ...
Shotaro Higuchi, Tsutomu Miyamoto, Miho Mochizuki, Tamae Fukushima, Koichi Ida, Hisanori Kobara, Ayumi Ohya, Yasunari Fujinaga, Tanri Shiozawa   +8 more
wiley   +1 more source

Utilization of Fertility Treatment in Japan During the First Year of Insurance Coverage: Analysis of Real‐World Health Claims Data

Reproductive Medicine and Biology, Volume 25, Issue 1, January/December 2026.
ABSTRACT Purpose In April 2022, fertility treatments, including assisted reproductive technology (ART), became eligible for public health insurance coverage in Japan. This study describes the prevalence and characteristics of infertility diagnoses and fertility treatments during the first year of coverage.
Makoto Okawara, Tomoichiro Kuwazuru, Moe Masunaga, Kenji Fujimoto, Masako Nagata, Takeshi Iwasa, Yoshihisa Fujino   +6 more
wiley   +1 more source

Venous thromboembolism in relation to ovarian hyperstimulation syndrome: an approach to determining the antithrombitic therapy effectiveness [PDF]

Гинекология, 2014
Ovarian hyperstimulation syndrome (OHSS) is a relatively common complication of ovarian stimulation. The pathophysiology of OHSS is characterised by increased capillary permeability.
I E Zazerskaya, N A Osipova, T V Vavilova, L V Barabanova, K S Konradi   +4 more
doaj  

Efficacy of Gonadotropin Releasing Hormone Antagonist (GnRHant) in Treatment of Severe Ovarian Hyperstimulation Syndrome (OHSS): a Randomized Controlled Trial [PDF]

Al-Azhar International Medical Journal
Background: The symptoms of ovarian hyperstimulation syndrome (OHSS), an unintentional and possibly lethal side effect of ovarian stimulation in assisted reproductive technology (ART), include rapid movement of fluid from the blood vessels to the space ...
Amgad mehawed, Ahmad amer, Ahmad Saeed
doaj   +1 more source